Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.66 |
| ▸ | TSHR | P16473 | 3/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.56 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.56 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.43 |
| ▸ | RARB | P10826 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8202060 | 0.96 | ALDH1A1 (0.70) | ALDH1A1TSHRMAPK1PRSS1PRSS2 | |
| SCHEMBL174632 | 0.91 | ALDH1A1 (0.79) | ALDH1A1TSHRMAPK1PRSS1PRSS2 | |
| SCHEMBL27675766 | 0.91 | ALDH1A1 (0.67) | ALDH1A1TSHRMAPK1PRSS1PRSS2 | |
| SCHEMBL28474740 | 0.90 | ALDH1A1 (0.62) | ALDH1A1TSHRMAPK1PRSS1PRSS2 | |
| SCHEMBL6747713 | 0.89 | ALDH1A1 (0.83) | ALDH1A1TSHRMAPK1PRSS1PRSS2 | |
| SCHEMBL27631103 | 0.88 | ALDH1A1 (0.77) | ALDH1A1TSHRMAPK1PRSS1PRSS2 | |
| SCHEMBL828867 | 0.88 | ALDH1A1 (0.85) | ALDH1A1TSHRMAPK1PRSS1PRSS2 | |
| SCHEMBL9355623 | 0.87 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1PRSS1PRSS2 | |
| SCHEMBL4267217 | 0.87 | ALDH1A1 (0.84) | ALDH1A1TSHRMAPK1PRSS1PRSS2 | |
| SCHEMBL4141137 | 0.86 | ALDH1A1 (0.79) | ALDH1A1TSHRMAPK1PRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040265347-A1 | Cosmetic composition comprising a sebum-absorbing powder and a powder with a low critical surface energy | L'OREAL S.A. (FR) | 2004-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040265347-A1 | Cosmetic composition comprising a sebum-absorbing powder and a powder with a low critical surface energy | CUTA, MITF, SAMM50 | ALDH1A1 4495/4885TSHR 1885/4885MAPK1 2800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.